MGI Tech Co., Ltd. (688114) Stock Price, News, Quotes-Moomoo

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

CN Stock MarketDetailed Quotes

688114 MGI Tech Co., Ltd.

Watchlist

45.66
-1.13-2.42%

Market Closed Jan 2 15:00 CST

19.02BMarket Cap-21.78P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Is MGI Tech (SHSE:688114) Using Debt In A Risky Way?
Simply Wall StDec 28, 2024 20:02 ET
Express News | Mgi Tech Closes Agreement With Sabin Group to Boost Personalized Medicine in Brazil Through Oncological and Germiline Genomics
ReutersDec 19, 2024 04:42 ET
MGI Tech Closes Agreement With Sabin Group to Boost Personalized Medicine in Brazil Through Oncological and Germiline Genomics
PR NewswireDec 19, 2024 04:42 ET
The crisis of the Biosafety Act has been resolved, and the stock price of BGI Genomics (688114.SH) rebounded today, rising by 4.49% after a significant decline.
On December 10, BGI Genomics (688114.SH) opened at 54.38 yuan, reached a high of 54.88 yuan, with a maximum increase of 7.19%, and closed at 53.50 yuan, up 4.49% from the previous Trade day, with a Turnover Ratio of 2.671%.
Zhitong FinanceDec 10, 2024 05:28 ET
Express News | Mgi Tech Announces Partnership With Universidad De San Martín De Porres to Strengthen Human Genetics Research
ReutersDec 1, 2024 22:16 ET
MGI Tech Announces Partnership With Universidad De San Martín De Porres to Strengthen Human Genetics Research
PR NewswireDec 1, 2024 22:16 ET

Comments

Moomoo AI

Feb 9, 2024 01:00

MGI Tech's conservative balance sheet could likely eliminate its debt easily. However, future earnings will determine its ability to maintain a healthy balance sheet. The company's revenue shrinkage and pre-interest, pre-tax loss last year is worrisome. The company may need to raise capital again soon.

Is MGI Tech (SHSE:688114) A Risky Investment?

Spinee

Jan 28, 2024 19:47

A bill to prohibit contracting with certain biotechnology providers, and for other purposes.

BGI, MGI, Complete Genomics, Wuxi Apptec, and any subsidiary are included.
Last Friday, WuXi AppTec's shares tumble by 20% in Hong Kong and fall by a 10% limit-down in mainland China.
Other CRO stocks including Medicilon are also falling.
$WUXI BIO (02269.HK)$ $WUXI APPTEC (02359.HK)$ $BGI Genomics (300676.SZ)$ $MGI Tech Co., Ltd. (688114.SH)$ $Shanghai Medicilon Inc. (688202.SH)$ $Novo-Nordisk A/S (NVO.US)$ $Hang Seng H-Share Index ETF (02828.HK)$

Moomoo AI

Dec 17, 2023 19:33

MGI Tech's P/S ratio may be overvalued amid poor revenue performance and average future growth estimates. Investors might be overpaying with no clear justification, risking long-term share price sustainability.